US 10336833
Conjugated anti-CD38 antibodies
granted A61KA61K2039/505A61K47/6871
Quick answer
US patent 10336833 (Conjugated anti-CD38 antibodies) held by Takeda Pharmaceutical Company Limited expires Mon Jun 27 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Jul 02 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 27 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 30
- CPC classes
- A61K, A61K2039/505, A61K47/6871, A61P, A61P1/00